E. Kamsteeg

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.

K. Heimdal, P. Møller, E. Hovig, 1997, European journal of cancer.

Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.

R. Hofstra, D. de Jong, C. Buys, 1996, The Journal of clinical endocrinology and metabolism.